Mount Sinai doctors are at the US Open again this year to provide care to all the athletes competing at the USTA Billie Jean King National Tennis Center Grounds in Flushing, New York until September 8, 2019. This is their seventh year as the office medical services provider for the athletes at the US Open.
Mount Sinai Celebrates 7 Years with US Open
1 min read Premium comments
Secondary#mtsinai#usopen
“Mount Sinai’s talented team of multidisciplinary sports medicine experts provides world-class, comprehensive care for all of the athletes during the tournament, including the pros, the juniors, and wheelchair tennis players, “said Alexis Chiang Colvin, M.D., associate professor of sports medicine in the Leni and Peter W. May Department of Orthopedic Surgery, Icahn School of Medicine at Mount Sinai, and team physician for the U.S. Fed Cup Team. He is also the chief medical officer for the US Open this year.
The radiology department at Mount Sinai is also providing diagnostic ultrasound examinations for players at the US Open with the LOGIQ e, a GE Healthcare ultrasound device that is only the size of a laptop so it can be used right there at the competition. The Mount Sinai radiology team will also be able to diagnose injured players with the CARESTREAM DRX-Revolution Mobile X-ray System, which is also portable and easy to use right there on the tennis grounds. For more complex injuries, injured players will be sent to Mount Sinai Hospital.
In addition to the medical care they are providing, Mount Sinai is also offering complimentary sunscreen every day and hand sanitizer every night of the US Open for both players and their fans.
On Thursday, September 5th, the rehabilitation team at Mount Sinai, led by Chair Joseph Herrera, D.O., will also be bringing rehab patients to the US Open for the US Open Wheelchair Competition. Patients will get the chance to meet the US Open wheelchair players and even play with them in a tennis match and drill at the Guggenheim Pavilion at Mount Sinai on Tuesday, September 3rd.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.